Physician profile
Shantharam Pai
NPI 1053317537
$810.84
in general payments reported to CMS, 2019-2025
12 companies · $186 in 2025
The $186 reported for 2025 was more than what a typical Geriatric Medicine (Family Medicine) provider received nationally (typical 2025 total: $119).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $140 · 2020: $215 · 2021: $110 · 2022: $19.35 · 2023: $21.71 · 2024: $119 · 2025: $186.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $327.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $327.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ucb, INC. | $245.47 | 2020-2021 | |
| Alkermes, INC. | $121.79 | 2025 | Lybalvi |
| Abbvie INC. | $119.39 | 2024 | |
| Cardinal Health 200 LLC | $114.05 | 2019 | |
| Bridgebio Pharma, INC. | $64.16 | 2025 | Attruby |
| Sunovion Pharmaceuticals INC. | $38.54 | 2020 | |
| Acadia Pharmaceuticals INC | $25.86 | 2019 | |
| Lilly USA, LLC | $21.71 | 2023 | Trulicity |
| Urovant Sciences INC | $19.35 | 2022 | |
| Xeris Pharmaceuticals, INC. | $15.90 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $12.46 | 2020 | |
| Biogen, INC. | $12.16 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Shantharam Pai listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.